Apollo BioTech co., ltd.

Assaya is a Singapore-based medical technology company specializing in rapid diagnostic solutions. The company's flagship product, the iaX Intelligent Analyzer, is a universal, portable rapid diagnostic reader that converts qualitative lateral flow assay (LFA) results into quantitative, machine-read data with cloud connectivity. The iaX eliminates subjectivity in test interpretation—addressing the 80% misread rate common in manual LFA reading—and delivers lab-grade diagnostic accuracy at the point of care in seconds. Compatible with rapid tests from major manufacturers (Abbott, BD, Roche, Abnova) without brand lock-in, iaX automatically syncs results to secure cloud storage with full metadata for EHR/LIMS/ERP integration. The platform supports human health diagnostics, livestock disease detection, aquaculture health monitoring, food safety screening, environmental and water testing, and public health/emergency response. Assaya's technology represents a cost-effective alternative to centralized PCR testing, enabling decentralized diagnostics across clinical, field, farm, and remote settings while maintaining regulatory compliance (FDA Class I IVD, IVD-CE, IVDR-EU, ANVISA).